Clinical trial number NCT00428090 for "Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease" at ClinicalTrials.gov
Clinical trial number NCT00348309 for "Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-2)" at ClinicalTrials.gov
Clinical trial number NCT00348140 for "Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease (REFLECT-3)" at ClinicalTrials.gov
Clinical trial number NCT00427362 for "A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)" at ClinicalTrials.gov
Jitta DJ, DeJongste MJ, Kliphuis CM, Staal MJ (January 2011). "Multimorbidity, the predominant predictor of quality-of-life, following successful spinal cord stimulation for angina pectoris". Neuromodulation. 14 (1): 13–8, discussion 18–9. doi:10.1111/j.1525-1403.2010.00321.x. PMID21992156. S2CID35519046.
Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, et al. (July 2013). "Effects of ivabradine and ranolazine in patients with microvascular angina pectoris". The American Journal of Cardiology. 112 (1): 8–13. doi:10.1016/j.amjcard.2013.02.045. PMID23558043.
Andréll P, Ekre O, Grip L, Währborg P, Albertsson P, Eliasson T, et al. (March 2011). "Fatality, morbidity and quality of life in patients with refractory angina pectoris". International Journal of Cardiology. 147 (3): 377–82. doi:10.1016/j.ijcard.2009.09.538. PMID19880202.
Kim MA, Ye YM, Park JW, Lee JH, Lee SK, Kim CW, et al. (2013). "A computerized asthma-specific quality of life: a novel tool for reflecting asthma control and predicting exacerbation". International Archives of Allergy and Immunology. 163 (1): 36–42. doi:10.1159/000356336. PMID24247849. S2CID37156455.
McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. (February 2005). "International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)". Quality of Life Research. 14 (1): 231–41. doi:10.1007/s11136-004-4231-z. PMID15789957. S2CID21412583.
Lambert J, Bostoen J, Geusens B, Bourgois J, Boone J, De Smedt D, Annemans L (January 2011). "A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results". Archives of Dermatological Research. 303 (1): 57–63. doi:10.1007/s00403-010-1082-z. PMID20842368. S2CID20817434.
Bostoen J, Bracke S, De Keyser S, Lambert J (November 2012). "An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial". The British Journal of Dermatology. 167 (5): 1025–31. doi:10.1111/j.1365-2133.2012.11113.x. PMID22709422. S2CID11139439.
Moed H, Yang Q, Oranje AP, Panda S, Van Der Wouden JC (2012). "Different strategies for using topical corticosteroids for established eczema". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010080. (Retracted, see doi:10.1002/14651858.cd010080.pub2. If this is an intentional citation to a retracted paper, please replace {{retracted|...}} with {{retracted|...|intentional=yes}}.)
Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC (May 2011). "Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis". International Journal of Rheumatic Diseases. 14 (2): 206–10. doi:10.1111/j.1756-185X.2010.01580.x. PMID21518321. S2CID6498018.
McKenna SP, Hunt SM (March 1994). "A measure of family disruption for use in chickenpox and other childhood illnesses". Social Science & Medicine. 38 (5): 725–31. doi:10.1016/0277-9536(94)90463-4. PMID8171351.
Bächinger D, Röösli C, Ditzen B, Huber AM (October 2016). "Development and validation of the Zurich chronic middle ear inventory (ZCMEI-21): an electronic questionnaire for assessing quality of life in patients with chronic otitis media". European Archives of Oto-Rhino-Laryngology. 273 (10): 3073–81. doi:10.1007/s00405-016-3915-7. PMID26869474. S2CID10107433.
Chatzimichalis, Michail; Epprecht, Lorenz; Weder, Stefan; Shaul, Chanan; Engle Folchert, Kristi J.; Machala, Maria C.; Goosmann, Madeline M.; Naville, Marc; Zhu, Angela; Röösli, Christof; Lee, Daniel J.; Cass, Stephen P.; Briggs, Robert; Huber, Alexander M.; Bächinger, David (2019). "English translation and validation of the Zurich chronic middle ear inventory (ZCMEI‐21‐E) assessing quality of life in chronic otitis media: A prospective international multicentre study". Clinical Otolaryngology. 44 (3): 254–262. doi:10.1111/coa.13275. hdl:11343/285278. PMID30588758. S2CID58610511.
Bächinger, David; Takagi, Daiki; Yamada, Hiroyuki; Teraoka, Masato; Okada, Masahiro; Hyodo, Jun; Röösli, Christof; Huber, Alexander M.; Hato, Naohito (2019). "Japanese translation, cross-cultural adaption and multicentre validation of the Zurich chronic middle ear inventory (ZCMEI-21-Jap)". Auris Nasus Larynx. 46 (1): 18–23. doi:10.1016/j.anl.2018.05.008. PMID29871811. S2CID46949869.
Weldam SW, Schuurmans MJ, Liu R, Lammers JW (May 2013). "Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review". International Journal of Nursing Studies. 50 (5): 688–707. doi:10.1016/j.ijnurstu.2012.07.017. PMID22921317.
López-Campos JL (2009). "[Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments]" [Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments]. Archivos de Bronconeumologia (in Spanish). 45 (Suppl 5): 2–6. doi:10.1016/S0300-2896(09)72948-5. PMID20116755.
Amir M, Lewin-Epstein N, Becker G, Buskila D (October 2002). "Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel". Medical Care. 40 (10): 918–28. doi:10.1097/00005650-200210000-00009. PMID12395025. S2CID25950087.
McKenna SP, Hunt SM (October 1992). "A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS". Health Policy. 22 (3): 321–30. doi:10.1016/0168-8510(92)90005-V. PMID10122731.
Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA (2002). "Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression". Journal of Psychiatric Research. 36 (6): 383–90. doi:10.1016/S0022-3956(02)00060-2. PMID12393307.
Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE (May 2006). "Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials". The Journal of Clinical Psychiatry. 67 (5): 761–70. doi:10.4088/JCP.v67n0510. PMID16841626.
da Conceição PO, Nascimento PP, Mazetto L, Alonso NB, Yacubian EM, de Araujo Filho GM (May 2013). "Are psychiatric disorders exclusion criteria for video-EEG monitoring and epilepsy surgery in patients with mesial temporal sclerosis?". Epilepsy & Behavior. 27 (2): 310–4. doi:10.1016/j.yebeh.2013.02.014. PMID23523814. S2CID566487.
Monteiro E, Osório F, Veriano A, Molina RS, Funayama SS, Terra VC, et al. (July 2012). "Validation of the Subjective Handicap of Epilepsy (SHE) in Brazilian patients with epilepsy". Epilepsy & Behavior. 24 (3): 345–51. doi:10.1016/j.yebeh.2012.04.129. PMID22658433. S2CID27975316.
Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. (May 2011). "Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration". Investigative Ophthalmology & Visual Science. 52 (6): 3354–9. doi:10.1167/iovs.10-5645. PMID21282568.
Kirwan C, Lanigan B, O'Keefe M (2012). "Vision-related quality of life assessment using the NEI-VFQ-25 in adolescents and young adults with a history of congenital cataract". Journal of Pediatric Ophthalmology and Strabismus. 49 (1): 26–31. doi:10.3928/01913913-20110517-02. PMID21598855.
Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA (December 2013). "Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis". Quality of Life Research. 22 (10): 2801–8. doi:10.1007/s11136-013-0412-y. PMID23645458. S2CID50961.
Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B (October 2009). "The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)". Multiple Sclerosis. 15 (10): 1228–38. doi:10.1177/1352458509106714. PMID19556314. S2CID23273125.
Maxwell A, Özmen M, Iezzi A, Richardson J (December 2016). "Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data". Quality of Life Research. 25 (12): 3209–3219. doi:10.1007/s11136-016-1337-z. PMID27344318. S2CID2153470.
Kaplan RM, Patterson TL, Kerner DN, Atkinson JH, Heaton RK, Grant I (August 1997). "The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center". Quality of Life Research. 6 (6): 507–14. doi:10.1023/A:1018456031659. PMID9330551. S2CID1253643.
Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL (1997). "Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients". Medical Decision Making. 17 (4): 439–46. CiteSeerX10.1.1.1004.6037. doi:10.1177/0272989X9701700409. PMID9343802. S2CID22869619.
Frosch DL, Kaplan RM, Ganiats TG, Groessl EJ, Sieber WJ, Weisman MH (February 2004). "Validity of self-administered quality of well-being scale in musculoskeletal disease". Arthritis and Rheumatism. 51 (1): 28–33. doi:10.1002/art.20071. PMID14872452.
Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, et al. (December 2014). "Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD". The European Journal of Health Economics. 15 (9): 967–77. doi:10.1007/s10198-013-0540-x. PMID24233919. S2CID20429564.
Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E (February 2014). "Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective". Bone. 59: 105–13. doi:10.1016/j.bone.2013.11.002. PMID24231131.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (May 1981). "The Nottingham Health Profile: subjective health status and medical consultations". Social Science & Medicine, Part A. 15 (3 Pt 1): 221–9. doi:10.1016/0271-7123(81)90005-5. PMID6973203.
Abulhasan M, Elshazly TA, Eida M, Albadry A (September 2013). "Giardia intestinalis in patients with nonulcer dyspepsia". Arab Journal of Gastroenterology. 14 (3): 126–9. doi:10.1016/j.ajg.2013.08.004. PMID24206742.
van Straten A, de Haan RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GA (November 1997). "A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30)". Stroke. 28 (11): 2155–61. doi:10.1161/01.STR.28.11.2155. PMID9368557.
Hulsebos RG, Beltman FW, dos Reis Miranda D, Spangenberg JF (1991). "Measuring quality of life with the sickness impact profile: a pilot study". Intensive Care Medicine. 17 (5): 285–8. doi:10.1007/BF01713939. PMID1939874. S2CID6394744.
Ebrahim S, Parshuram C (March 2015). "Comparison of utility scores from the Visual Analog Scale and Health Utilities Index 3 in children following pediatric intensive care unit admission". Journal of Child Health Care. 19 (1): 53–62. doi:10.1177/1367493513496909. PMID23939724. S2CID23422052.
Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, Thorsen H (February 1998). "The international development of the RGHQoL: a quality of life measure for recurrent genital herpes". Quality of Life Research. 7 (2): 143–53. doi:10.1023/A:1008857426633. PMID9523496. S2CID19058639.
Bartlett BL, Tyring SK, Fife K, Gnann JW, Hadala JT, Kianifard F, Berber E (October 2008). "Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial". Journal of Clinical Virology. 43 (2): 190–5. doi:10.1016/j.jcv.2008.06.004. PMID18621575.
Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC (October 2001). "Patients' perspectives on the burden of recurrent genital herpes". International Journal of STD & AIDS. 12 (10): 640–5. doi:10.1258/0956462011923859. PMID11564330. S2CID32358251.
Wirén L, Whalley D, McKenna S, Wilhelmsen L (February 2000). "Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis". Clinical Endocrinology. 52 (2): 143–52. doi:10.1046/j.1365-2265.2000.00899.x. PMID10671940. S2CID11256536.
Moock J, Friedrich N, Völzke H, Spielhagen C, Nauck M, Koltowska-Häggström M, et al. (October 2011). "Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort". Growth Hormone & IGF Research. 21 (5): 272–8. doi:10.1016/j.ghir.2011.07.005. PMID21865066.
Badia X, Lucas A, Sanmartí A, Roset M, Ulied A (December 1998). "One-year follow-up of quality of life in adults with untreated growth hormone deficiency". Clinical Endocrinology. 49 (6): 765–71. doi:10.1046/j.1365-2265.1998.00634.x. PMID10209564. S2CID31044474.
Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, Mattsson AF, Svensson D, Westberg B, Luger A (January 2008). "Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)". Pharmacoepidemiology and Drug Safety. 17 (1): 90–102. doi:10.1002/pds.1510. PMID17957812. S2CID31206757.
Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (October 1994). "Development of the kidney disease quality of life (KDQOL) instrument". Quality of Life Research. 3 (5): 329–38. doi:10.1007/BF00451725. PMID7841967. S2CID41098376.
Cortés-Sanabria L, Paredes-Ceseña CA, Herrera-Llamas RM, Cruz-Bueno Y, Soto-Molina H, Pazarín L, et al. (November 2013). "Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis". Archives of Medical Research. 44 (8): 655–61. doi:10.1016/j.arcmed.2013.10.017. PMID24211750.
Garcia-Monco JC, Foncea N, Bilbao A, Ruiz de Velasco I, Gomez-Beldarrain M (August 2007). "Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients". Cephalalgia. 27 (8): 920–8. doi:10.1111/j.1468-2982.2007.01367.x. PMID17645757. S2CID9406164.
Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F (April 2013). "Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients". Multiple Sclerosis. 19 (5): 631–8. doi:10.1177/1352458512463481. PMID23069874. S2CID6838286.
McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J (February 2006). "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension". Quality of Life Research. 15 (1): 103–15. doi:10.1007/s11136-005-3513-4. PMID16411035. S2CID23830883.
Tay EL, Papaphylactou M, Diller GP, Alonso-Gonzalez R, Inuzuka R, Giannakoulas G, et al. (June 2011). "Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy". International Journal of Cardiology. 149 (3): 372–6. doi:10.1016/j.ijcard.2010.02.020. PMID20304507.
Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, et al. (August 2008). "Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension". Chest. 134 (2): 229–236. doi:10.1378/chest.07-2681. PMID18263674.
McKenna SP, Lebwohl M, Kahler KN (June 2005). "Development of the US PSORIQoL: a psoriasis-specific measure of quality of life". International Journal of Dermatology. 44 (6): 462–9. doi:10.1111/j.1365-4632.2005.01941.x. PMID15941432. S2CID22163460.
McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, Van Assche D (August 2003). "Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials". The British Journal of Dermatology. 149 (2): 323–31. doi:10.1046/j.1365-2133.2003.05492.x. PMID12932239. S2CID26091210.
Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, et al. (August 2010). "Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey". Scandinavian Journal of Rheumatology. 39 (4): 303–9. doi:10.3109/03009740903468982. PMID20166848. S2CID26425942.
Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A (May 2010). "The patient-reported impact of scars measure: development and validation". Plastic and Reconstructive Surgery. 125 (5): 1439–49. doi:10.1097/PRS.0b013e3181d4fd89. PMID20440163.
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (February 2009). "The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus". Annals of the Rheumatic Diseases. 68 (2): 196–200. doi:10.1136/ard.2007.086009. PMID18385276. S2CID23886698.
"Measures Database". Galen-Research.com. Galen Research. Retrieved 11 October 2013.
"Measures Database". Galen-Research.com. Galen Research. Retrieved 20 November 2013.
"Measures Database". Galen-Research.com. Galen Research. Retrieved 2 October 2013.
"Measures Database". Galen-Research.com. Galen Research. Retrieved 13 November 2013.
handle.net
hdl.handle.net
Chatzimichalis, Michail; Epprecht, Lorenz; Weder, Stefan; Shaul, Chanan; Engle Folchert, Kristi J.; Machala, Maria C.; Goosmann, Madeline M.; Naville, Marc; Zhu, Angela; Röösli, Christof; Lee, Daniel J.; Cass, Stephen P.; Briggs, Robert; Huber, Alexander M.; Bächinger, David (2019). "English translation and validation of the Zurich chronic middle ear inventory (ZCMEI‐21‐E) assessing quality of life in chronic otitis media: A prospective international multicentre study". Clinical Otolaryngology. 44 (3): 254–262. doi:10.1111/coa.13275. hdl:11343/285278. PMID30588758. S2CID58610511.
Jitta DJ, DeJongste MJ, Kliphuis CM, Staal MJ (January 2011). "Multimorbidity, the predominant predictor of quality-of-life, following successful spinal cord stimulation for angina pectoris". Neuromodulation. 14 (1): 13–8, discussion 18–9. doi:10.1111/j.1525-1403.2010.00321.x. PMID21992156. S2CID35519046.
Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, et al. (July 2013). "Effects of ivabradine and ranolazine in patients with microvascular angina pectoris". The American Journal of Cardiology. 112 (1): 8–13. doi:10.1016/j.amjcard.2013.02.045. PMID23558043.
Andréll P, Ekre O, Grip L, Währborg P, Albertsson P, Eliasson T, et al. (March 2011). "Fatality, morbidity and quality of life in patients with refractory angina pectoris". International Journal of Cardiology. 147 (3): 377–82. doi:10.1016/j.ijcard.2009.09.538. PMID19880202.
Kim MA, Ye YM, Park JW, Lee JH, Lee SK, Kim CW, et al. (2013). "A computerized asthma-specific quality of life: a novel tool for reflecting asthma control and predicting exacerbation". International Archives of Allergy and Immunology. 163 (1): 36–42. doi:10.1159/000356336. PMID24247849. S2CID37156455.
McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. (February 2005). "International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)". Quality of Life Research. 14 (1): 231–41. doi:10.1007/s11136-004-4231-z. PMID15789957. S2CID21412583.
Lambert J, Bostoen J, Geusens B, Bourgois J, Boone J, De Smedt D, Annemans L (January 2011). "A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results". Archives of Dermatological Research. 303 (1): 57–63. doi:10.1007/s00403-010-1082-z. PMID20842368. S2CID20817434.
Bostoen J, Bracke S, De Keyser S, Lambert J (November 2012). "An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial". The British Journal of Dermatology. 167 (5): 1025–31. doi:10.1111/j.1365-2133.2012.11113.x. PMID22709422. S2CID11139439.
Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC (May 2011). "Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis". International Journal of Rheumatic Diseases. 14 (2): 206–10. doi:10.1111/j.1756-185X.2010.01580.x. PMID21518321. S2CID6498018.
McKenna SP, Hunt SM (March 1994). "A measure of family disruption for use in chickenpox and other childhood illnesses". Social Science & Medicine. 38 (5): 725–31. doi:10.1016/0277-9536(94)90463-4. PMID8171351.
Bächinger D, Röösli C, Ditzen B, Huber AM (October 2016). "Development and validation of the Zurich chronic middle ear inventory (ZCMEI-21): an electronic questionnaire for assessing quality of life in patients with chronic otitis media". European Archives of Oto-Rhino-Laryngology. 273 (10): 3073–81. doi:10.1007/s00405-016-3915-7. PMID26869474. S2CID10107433.
Chatzimichalis, Michail; Epprecht, Lorenz; Weder, Stefan; Shaul, Chanan; Engle Folchert, Kristi J.; Machala, Maria C.; Goosmann, Madeline M.; Naville, Marc; Zhu, Angela; Röösli, Christof; Lee, Daniel J.; Cass, Stephen P.; Briggs, Robert; Huber, Alexander M.; Bächinger, David (2019). "English translation and validation of the Zurich chronic middle ear inventory (ZCMEI‐21‐E) assessing quality of life in chronic otitis media: A prospective international multicentre study". Clinical Otolaryngology. 44 (3): 254–262. doi:10.1111/coa.13275. hdl:11343/285278. PMID30588758. S2CID58610511.
Bächinger, David; Takagi, Daiki; Yamada, Hiroyuki; Teraoka, Masato; Okada, Masahiro; Hyodo, Jun; Röösli, Christof; Huber, Alexander M.; Hato, Naohito (2019). "Japanese translation, cross-cultural adaption and multicentre validation of the Zurich chronic middle ear inventory (ZCMEI-21-Jap)". Auris Nasus Larynx. 46 (1): 18–23. doi:10.1016/j.anl.2018.05.008. PMID29871811. S2CID46949869.
Weldam SW, Schuurmans MJ, Liu R, Lammers JW (May 2013). "Evaluation of Quality of Life instruments for use in COPD care and research: a systematic review". International Journal of Nursing Studies. 50 (5): 688–707. doi:10.1016/j.ijnurstu.2012.07.017. PMID22921317.
López-Campos JL (2009). "[Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments]" [Importance of fatigue, sleep quality and mood in patients with chronic obstructive pulmonary disease and the need for measurement instruments]. Archivos de Bronconeumologia (in Spanish). 45 (Suppl 5): 2–6. doi:10.1016/S0300-2896(09)72948-5. PMID20116755.
Amir M, Lewin-Epstein N, Becker G, Buskila D (October 2002). "Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel". Medical Care. 40 (10): 918–28. doi:10.1097/00005650-200210000-00009. PMID12395025. S2CID25950087.
McKenna SP, Hunt SM (October 1992). "A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS". Health Policy. 22 (3): 321–30. doi:10.1016/0168-8510(92)90005-V. PMID10122731.
Baca Baldomero E, Cervera Enguix S (2003). "[Quality of life, in depressed patients in Primary Health Care setting. Effectiveness and safety of venlafaxine extended release]". Actas Españolas de Psiquiatría. 31 (6): 331–8. PMID14639509.
Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA (2002). "Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression". Journal of Psychiatric Research. 36 (6): 383–90. doi:10.1016/S0022-3956(02)00060-2. PMID12393307.
Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE (May 2006). "Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials". The Journal of Clinical Psychiatry. 67 (5): 761–70. doi:10.4088/JCP.v67n0510. PMID16841626.
da Conceição PO, Nascimento PP, Mazetto L, Alonso NB, Yacubian EM, de Araujo Filho GM (May 2013). "Are psychiatric disorders exclusion criteria for video-EEG monitoring and epilepsy surgery in patients with mesial temporal sclerosis?". Epilepsy & Behavior. 27 (2): 310–4. doi:10.1016/j.yebeh.2013.02.014. PMID23523814. S2CID566487.
Monteiro E, Osório F, Veriano A, Molina RS, Funayama SS, Terra VC, et al. (July 2012). "Validation of the Subjective Handicap of Epilepsy (SHE) in Brazilian patients with epilepsy". Epilepsy & Behavior. 24 (3): 345–51. doi:10.1016/j.yebeh.2012.04.129. PMID22658433. S2CID27975316.
Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. (May 2011). "Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration". Investigative Ophthalmology & Visual Science. 52 (6): 3354–9. doi:10.1167/iovs.10-5645. PMID21282568.
Kirwan C, Lanigan B, O'Keefe M (2012). "Vision-related quality of life assessment using the NEI-VFQ-25 in adolescents and young adults with a history of congenital cataract". Journal of Pediatric Ophthalmology and Strabismus. 49 (1): 26–31. doi:10.3928/01913913-20110517-02. PMID21598855.
Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA (December 2013). "Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis". Quality of Life Research. 22 (10): 2801–8. doi:10.1007/s11136-013-0412-y. PMID23645458. S2CID50961.
Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B (October 2009). "The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)". Multiple Sclerosis. 15 (10): 1228–38. doi:10.1177/1352458509106714. PMID19556314. S2CID23273125.
Maxwell A, Özmen M, Iezzi A, Richardson J (December 2016). "Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data". Quality of Life Research. 25 (12): 3209–3219. doi:10.1007/s11136-016-1337-z. PMID27344318. S2CID2153470.
Kaplan RM, Patterson TL, Kerner DN, Atkinson JH, Heaton RK, Grant I (August 1997). "The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center". Quality of Life Research. 6 (6): 507–14. doi:10.1023/A:1018456031659. PMID9330551. S2CID1253643.
Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL (1997). "Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients". Medical Decision Making. 17 (4): 439–46. CiteSeerX10.1.1.1004.6037. doi:10.1177/0272989X9701700409. PMID9343802. S2CID22869619.
Frosch DL, Kaplan RM, Ganiats TG, Groessl EJ, Sieber WJ, Weisman MH (February 2004). "Validity of self-administered quality of well-being scale in musculoskeletal disease". Arthritis and Rheumatism. 51 (1): 28–33. doi:10.1002/art.20071. PMID14872452.
Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, et al. (December 2014). "Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD". The European Journal of Health Economics. 15 (9): 967–77. doi:10.1007/s10198-013-0540-x. PMID24233919. S2CID20429564.
Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E (February 2014). "Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective". Bone. 59: 105–13. doi:10.1016/j.bone.2013.11.002. PMID24231131.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (May 1981). "The Nottingham Health Profile: subjective health status and medical consultations". Social Science & Medicine, Part A. 15 (3 Pt 1): 221–9. doi:10.1016/0271-7123(81)90005-5. PMID6973203.
Abulhasan M, Elshazly TA, Eida M, Albadry A (September 2013). "Giardia intestinalis in patients with nonulcer dyspepsia". Arab Journal of Gastroenterology. 14 (3): 126–9. doi:10.1016/j.ajg.2013.08.004. PMID24206742.
van Straten A, de Haan RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GA (November 1997). "A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30)". Stroke. 28 (11): 2155–61. doi:10.1161/01.STR.28.11.2155. PMID9368557.
Hulsebos RG, Beltman FW, dos Reis Miranda D, Spangenberg JF (1991). "Measuring quality of life with the sickness impact profile: a pilot study". Intensive Care Medicine. 17 (5): 285–8. doi:10.1007/BF01713939. PMID1939874. S2CID6394744.
Ebrahim S, Parshuram C (March 2015). "Comparison of utility scores from the Visual Analog Scale and Health Utilities Index 3 in children following pediatric intensive care unit admission". Journal of Child Health Care. 19 (1): 53–62. doi:10.1177/1367493513496909. PMID23939724. S2CID23422052.
Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, Thorsen H (February 1998). "The international development of the RGHQoL: a quality of life measure for recurrent genital herpes". Quality of Life Research. 7 (2): 143–53. doi:10.1023/A:1008857426633. PMID9523496. S2CID19058639.
Bartlett BL, Tyring SK, Fife K, Gnann JW, Hadala JT, Kianifard F, Berber E (October 2008). "Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial". Journal of Clinical Virology. 43 (2): 190–5. doi:10.1016/j.jcv.2008.06.004. PMID18621575.
Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC (October 2001). "Patients' perspectives on the burden of recurrent genital herpes". International Journal of STD & AIDS. 12 (10): 640–5. doi:10.1258/0956462011923859. PMID11564330. S2CID32358251.
Wirén L, Whalley D, McKenna S, Wilhelmsen L (February 2000). "Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis". Clinical Endocrinology. 52 (2): 143–52. doi:10.1046/j.1365-2265.2000.00899.x. PMID10671940. S2CID11256536.
Moock J, Friedrich N, Völzke H, Spielhagen C, Nauck M, Koltowska-Häggström M, et al. (October 2011). "Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort". Growth Hormone & IGF Research. 21 (5): 272–8. doi:10.1016/j.ghir.2011.07.005. PMID21865066.
Badia X, Lucas A, Sanmartí A, Roset M, Ulied A (December 1998). "One-year follow-up of quality of life in adults with untreated growth hormone deficiency". Clinical Endocrinology. 49 (6): 765–71. doi:10.1046/j.1365-2265.1998.00634.x. PMID10209564. S2CID31044474.
Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, Mattsson AF, Svensson D, Westberg B, Luger A (January 2008). "Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)". Pharmacoepidemiology and Drug Safety. 17 (1): 90–102. doi:10.1002/pds.1510. PMID17957812. S2CID31206757.
Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (October 1994). "Development of the kidney disease quality of life (KDQOL) instrument". Quality of Life Research. 3 (5): 329–38. doi:10.1007/BF00451725. PMID7841967. S2CID41098376.
Cortés-Sanabria L, Paredes-Ceseña CA, Herrera-Llamas RM, Cruz-Bueno Y, Soto-Molina H, Pazarín L, et al. (November 2013). "Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis". Archives of Medical Research. 44 (8): 655–61. doi:10.1016/j.arcmed.2013.10.017. PMID24211750.
Garcia-Monco JC, Foncea N, Bilbao A, Ruiz de Velasco I, Gomez-Beldarrain M (August 2007). "Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients". Cephalalgia. 27 (8): 920–8. doi:10.1111/j.1468-2982.2007.01367.x. PMID17645757. S2CID9406164.
Mérelle SY, Sorbi MJ, van Doornen LJ, Passchier J (February 2008). "Migraine patients as trainers of their fellow patients in non-pharmacological preventive attack management: short-term effects of a randomized controlled trial". Cephalalgia. 28 (2): 127–38. doi:10.1111/j.1468-2982.2007.01472.x. PMID18197883. S2CID44246726.
Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ (September 2009). "The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)". Multiple Sclerosis. 15 (9): 1092–102. doi:10.1177/1352458509106513. PMID19556315. S2CID7459469.
Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F (April 2013). "Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients". Multiple Sclerosis. 19 (5): 631–8. doi:10.1177/1352458512463481. PMID23069874. S2CID6838286.
McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J (February 2006). "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension". Quality of Life Research. 15 (1): 103–15. doi:10.1007/s11136-005-3513-4. PMID16411035. S2CID23830883.
Tay EL, Papaphylactou M, Diller GP, Alonso-Gonzalez R, Inuzuka R, Giannakoulas G, et al. (June 2011). "Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy". International Journal of Cardiology. 149 (3): 372–6. doi:10.1016/j.ijcard.2010.02.020. PMID20304507.
Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, et al. (August 2008). "Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension". Chest. 134 (2): 229–236. doi:10.1378/chest.07-2681. PMID18263674.
McKenna SP, Lebwohl M, Kahler KN (June 2005). "Development of the US PSORIQoL: a psoriasis-specific measure of quality of life". International Journal of Dermatology. 44 (6): 462–9. doi:10.1111/j.1365-4632.2005.01941.x. PMID15941432. S2CID22163460.
McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, Van Assche D (August 2003). "Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials". The British Journal of Dermatology. 149 (2): 323–31. doi:10.1046/j.1365-2133.2003.05492.x. PMID12932239. S2CID26091210.
Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, et al. (August 2010). "Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey". Scandinavian Journal of Rheumatology. 39 (4): 303–9. doi:10.3109/03009740903468982. PMID20166848. S2CID26425942.
Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A (May 2010). "The patient-reported impact of scars measure: development and validation". Plastic and Reconstructive Surgery. 125 (5): 1439–49. doi:10.1097/PRS.0b013e3181d4fd89. PMID20440163.
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (February 2009). "The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus". Annals of the Rheumatic Diseases. 68 (2): 196–200. doi:10.1136/ard.2007.086009. PMID18385276. S2CID23886698.
Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL (1997). "Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients". Medical Decision Making. 17 (4): 439–46. CiteSeerX10.1.1.1004.6037. doi:10.1177/0272989X9701700409. PMID9343802. S2CID22869619.
Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N (March 2012). "Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?". Drugs & Aging. 29 (3): 167–179. doi:10.2165/11599140-000000000-00000. PMID22350526. S2CID207301505.
Jitta DJ, DeJongste MJ, Kliphuis CM, Staal MJ (January 2011). "Multimorbidity, the predominant predictor of quality-of-life, following successful spinal cord stimulation for angina pectoris". Neuromodulation. 14 (1): 13–8, discussion 18–9. doi:10.1111/j.1525-1403.2010.00321.x. PMID21992156. S2CID35519046.
Kim MA, Ye YM, Park JW, Lee JH, Lee SK, Kim CW, et al. (2013). "A computerized asthma-specific quality of life: a novel tool for reflecting asthma control and predicting exacerbation". International Archives of Allergy and Immunology. 163 (1): 36–42. doi:10.1159/000356336. PMID24247849. S2CID37156455.
McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, et al. (February 2005). "International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)". Quality of Life Research. 14 (1): 231–41. doi:10.1007/s11136-004-4231-z. PMID15789957. S2CID21412583.
Lambert J, Bostoen J, Geusens B, Bourgois J, Boone J, De Smedt D, Annemans L (January 2011). "A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results". Archives of Dermatological Research. 303 (1): 57–63. doi:10.1007/s00403-010-1082-z. PMID20842368. S2CID20817434.
Bostoen J, Bracke S, De Keyser S, Lambert J (November 2012). "An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial". The British Journal of Dermatology. 167 (5): 1025–31. doi:10.1111/j.1365-2133.2012.11113.x. PMID22709422. S2CID11139439.
Xie F, Ye H, Zhang Y, Liu X, Lei T, Li SC (May 2011). "Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis". International Journal of Rheumatic Diseases. 14 (2): 206–10. doi:10.1111/j.1756-185X.2010.01580.x. PMID21518321. S2CID6498018.
Bächinger D, Röösli C, Ditzen B, Huber AM (October 2016). "Development and validation of the Zurich chronic middle ear inventory (ZCMEI-21): an electronic questionnaire for assessing quality of life in patients with chronic otitis media". European Archives of Oto-Rhino-Laryngology. 273 (10): 3073–81. doi:10.1007/s00405-016-3915-7. PMID26869474. S2CID10107433.
Chatzimichalis, Michail; Epprecht, Lorenz; Weder, Stefan; Shaul, Chanan; Engle Folchert, Kristi J.; Machala, Maria C.; Goosmann, Madeline M.; Naville, Marc; Zhu, Angela; Röösli, Christof; Lee, Daniel J.; Cass, Stephen P.; Briggs, Robert; Huber, Alexander M.; Bächinger, David (2019). "English translation and validation of the Zurich chronic middle ear inventory (ZCMEI‐21‐E) assessing quality of life in chronic otitis media: A prospective international multicentre study". Clinical Otolaryngology. 44 (3): 254–262. doi:10.1111/coa.13275. hdl:11343/285278. PMID30588758. S2CID58610511.
Bächinger, David; Takagi, Daiki; Yamada, Hiroyuki; Teraoka, Masato; Okada, Masahiro; Hyodo, Jun; Röösli, Christof; Huber, Alexander M.; Hato, Naohito (2019). "Japanese translation, cross-cultural adaption and multicentre validation of the Zurich chronic middle ear inventory (ZCMEI-21-Jap)". Auris Nasus Larynx. 46 (1): 18–23. doi:10.1016/j.anl.2018.05.008. PMID29871811. S2CID46949869.
Amir M, Lewin-Epstein N, Becker G, Buskila D (October 2002). "Psychometric properties of the SF-12 (Hebrew version) in a primary care population in Israel". Medical Care. 40 (10): 918–28. doi:10.1097/00005650-200210000-00009. PMID12395025. S2CID25950087.
da Conceição PO, Nascimento PP, Mazetto L, Alonso NB, Yacubian EM, de Araujo Filho GM (May 2013). "Are psychiatric disorders exclusion criteria for video-EEG monitoring and epilepsy surgery in patients with mesial temporal sclerosis?". Epilepsy & Behavior. 27 (2): 310–4. doi:10.1016/j.yebeh.2013.02.014. PMID23523814. S2CID566487.
Monteiro E, Osório F, Veriano A, Molina RS, Funayama SS, Terra VC, et al. (July 2012). "Validation of the Subjective Handicap of Epilepsy (SHE) in Brazilian patients with epilepsy". Epilepsy & Behavior. 24 (3): 345–51. doi:10.1016/j.yebeh.2012.04.129. PMID22658433. S2CID27975316.
Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA (December 2013). "Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis". Quality of Life Research. 22 (10): 2801–8. doi:10.1007/s11136-013-0412-y. PMID23645458. S2CID50961.
Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B (October 2009). "The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)". Multiple Sclerosis. 15 (10): 1228–38. doi:10.1177/1352458509106714. PMID19556314. S2CID23273125.
Maxwell A, Özmen M, Iezzi A, Richardson J (December 2016). "Deriving population norms for the AQoL-6D and AQoL-8D multi-attribute utility instruments from web-based data". Quality of Life Research. 25 (12): 3209–3219. doi:10.1007/s11136-016-1337-z. PMID27344318. S2CID2153470.
Kaplan RM, Patterson TL, Kerner DN, Atkinson JH, Heaton RK, Grant I (August 1997). "The Quality of Well-Being scale in asymptomatic HIV-infected patients. HNRC Group. HIV Neural Behavioral Research Center". Quality of Life Research. 6 (6): 507–14. doi:10.1023/A:1018456031659. PMID9330551. S2CID1253643.
Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL (1997). "Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients". Medical Decision Making. 17 (4): 439–46. CiteSeerX10.1.1.1004.6037. doi:10.1177/0272989X9701700409. PMID9343802. S2CID22869619.
Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, et al. (December 2014). "Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD". The European Journal of Health Economics. 15 (9): 967–77. doi:10.1007/s10198-013-0540-x. PMID24233919. S2CID20429564.
Behan LA, Rogers B, Hannon MJ, O'Kelly P, Tormey W, Smith D, et al. (October 2011). "Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients". Clinical Endocrinology. 75 (4): 505–13. doi:10.1111/j.1365-2265.2011.04074.x. PMID21521342. S2CID205286522.
Aydemir G, Tezer MS, Borman P, Bodur H, Unal A (June 2006). "Treatment of tinnitus with transcutaneous electrical nerve stimulation improves patients' quality of life". The Journal of Laryngology and Otology. 120 (6): 442–5. doi:10.1017/S0022215106000910. PMID16556347. S2CID43430574.
Hulsebos RG, Beltman FW, dos Reis Miranda D, Spangenberg JF (1991). "Measuring quality of life with the sickness impact profile: a pilot study". Intensive Care Medicine. 17 (5): 285–8. doi:10.1007/BF01713939. PMID1939874. S2CID6394744.
Ebrahim S, Parshuram C (March 2015). "Comparison of utility scores from the Visual Analog Scale and Health Utilities Index 3 in children following pediatric intensive care unit admission". Journal of Child Health Care. 19 (1): 53–62. doi:10.1177/1367493513496909. PMID23939724. S2CID23422052.
Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, Thorsen H (February 1998). "The international development of the RGHQoL: a quality of life measure for recurrent genital herpes". Quality of Life Research. 7 (2): 143–53. doi:10.1023/A:1008857426633. PMID9523496. S2CID19058639.
Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC (October 2001). "Patients' perspectives on the burden of recurrent genital herpes". International Journal of STD & AIDS. 12 (10): 640–5. doi:10.1258/0956462011923859. PMID11564330. S2CID32358251.
Wirén L, Whalley D, McKenna S, Wilhelmsen L (February 2000). "Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis". Clinical Endocrinology. 52 (2): 143–52. doi:10.1046/j.1365-2265.2000.00899.x. PMID10671940. S2CID11256536.
Badia X, Lucas A, Sanmartí A, Roset M, Ulied A (December 1998). "One-year follow-up of quality of life in adults with untreated growth hormone deficiency". Clinical Endocrinology. 49 (6): 765–71. doi:10.1046/j.1365-2265.1998.00634.x. PMID10209564. S2CID31044474.
Gutiérrez LP, Kołtowska-Häggström M, Jönsson PJ, Mattsson AF, Svensson D, Westberg B, Luger A (January 2008). "Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)". Pharmacoepidemiology and Drug Safety. 17 (1): 90–102. doi:10.1002/pds.1510. PMID17957812. S2CID31206757.
Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (October 1994). "Development of the kidney disease quality of life (KDQOL) instrument". Quality of Life Research. 3 (5): 329–38. doi:10.1007/BF00451725. PMID7841967. S2CID41098376.
Garcia-Monco JC, Foncea N, Bilbao A, Ruiz de Velasco I, Gomez-Beldarrain M (August 2007). "Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients". Cephalalgia. 27 (8): 920–8. doi:10.1111/j.1468-2982.2007.01367.x. PMID17645757. S2CID9406164.
Mérelle SY, Sorbi MJ, van Doornen LJ, Passchier J (February 2008). "Migraine patients as trainers of their fellow patients in non-pharmacological preventive attack management: short-term effects of a randomized controlled trial". Cephalalgia. 28 (2): 127–38. doi:10.1111/j.1468-2982.2007.01472.x. PMID18197883. S2CID44246726.
Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ (September 2009). "The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)". Multiple Sclerosis. 15 (9): 1092–102. doi:10.1177/1352458509106513. PMID19556315. S2CID7459469.
Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F (April 2013). "Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients". Multiple Sclerosis. 19 (5): 631–8. doi:10.1177/1352458512463481. PMID23069874. S2CID6838286.
McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J (February 2006). "The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension". Quality of Life Research. 15 (1): 103–15. doi:10.1007/s11136-005-3513-4. PMID16411035. S2CID23830883.
McKenna SP, Lebwohl M, Kahler KN (June 2005). "Development of the US PSORIQoL: a psoriasis-specific measure of quality of life". International Journal of Dermatology. 44 (6): 462–9. doi:10.1111/j.1365-4632.2005.01941.x. PMID15941432. S2CID22163460.
McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CE, Van Assche D (August 2003). "Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials". The British Journal of Dermatology. 149 (2): 323–31. doi:10.1046/j.1365-2133.2003.05492.x. PMID12932239. S2CID26091210.
Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, et al. (August 2010). "Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey". Scandinavian Journal of Rheumatology. 39 (4): 303–9. doi:10.3109/03009740903468982. PMID20166848. S2CID26425942.
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (February 2009). "The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus". Annals of the Rheumatic Diseases. 68 (2): 196–200. doi:10.1136/ard.2007.086009. PMID18385276. S2CID23886698.